PROCEPT BioRobotics Corp
Nasdaq · Surgical & Medical Instruments & Apparatus
Company Overview
A concise company profile alongside the latest public filing activity.
PROCEPT BioRobotics develops and sells the AQUABEAM Robotic System, a surgical device that uses image-guided, waterjet-based tissue resection to treat benign prostatic hyperplasia (enlarged prostate), along with related disposable handpieces and accessories used in each procedure.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Sharma PoojaChief Strat/Marketing Officer | Sell | $93K | 4,710at $19.71 | Nov 6, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable PRCT activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.